API | trilithium citrate

trilithium citrate Report issue

Small molecule Approved ^FDA

ChEMBL Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW

Lithium citrate (Li3C6H5O7) is a lithium salt of citric acid that is used as a mood stabilizer in psychiatric treatment of manic states and bipolar disorder. There is extensive pharmacology of lithium, the active component of this salt. ^Wikipedia

Chemistry

SMILES: [Li+].[Li+].[Li+].OC(CC(=O)[O-])(CC(=O)[O-])C(=O)[O-]
InChIKey: WJSIUCDMWSDDCE-UHFFFAOYSA-K
Mol. Mass: 209.92
ALogP: Missing data
ChEMBL Molecules:

lithium citrate

lithium citrate

More Chemistry

Pharmacology

Mechanisms of Action:
- Glycogen synthase kinase-3 alpha (Homo sapiens) ^UniProt
- Glycogen synthase kinase-3 beta (Homo sapiens) ^UniProt
- Inositol monophosphatase 1 (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: Yes
Availability: Prescription Only
Delivery Methods: Oral
Pro Drug: No

Organizations (6)

Research & Development (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (6)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (1)

Approved Indications (1)

Bipolar Disorder (approved 1980)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue